Synthesis of two novel azilsartan cocrystals: Preparation, physicochemical characterization and solubility studies

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Azilsartan is a novel angiotension II receptor blocker primarily used to treat high blood pressure. This is not a formulation-friendly molecule largely due to the inherent water-solubility pitfalls. In this paper, two novel cocrystals of azilsartan (AZ) were studied (AZ-BIP, AZ-BPE; BIP = 4,4′-bipyridine, BPE = trans-1,2-bis (4-pyridyl) ethylene) by solution crystallization. The structures of these two cocrystals were characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA), including the single-crystal structure determination of AZ-BIP and AZ-BPE. In the cocrystals AZ-BIP (2:1) and AZ-BPE (2:1), two AZ molecules and one coformer formed a sandwich structure through N-H … N interactions. These sandwich structures were extended into a one-dimensional structure through O-H … N hydrogen bonds. The equilibrium solubility study demonstrated that the AZ-BIP and AZ-BPE cocrystals both showed higher solubility than azilsartan in water.

Cite

CITATION STYLE

APA

Gao, L., & Zhang, X. R. (2020). Synthesis of two novel azilsartan cocrystals: Preparation, physicochemical characterization and solubility studies. Crystals, 10(9), 1–11. https://doi.org/10.3390/cryst10090739

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free